デフォルト表紙
市場調査レポート
商品コード
1596902

静注液の市場規模、シェア、成長分析、製品別、栄養素別、地域別 - 産業予測、2024年~2031年

Intravenous Solutions Market Size, Share, Growth Analysis, By Product (Total Parenteral Nutrition and Peripheral Parenteral Nutrition), By Nutrients (Carbohydrates, Parenteral Lipid Emulsion), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 192 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.81円
静注液の市場規模、シェア、成長分析、製品別、栄養素別、地域別 - 産業予測、2024年~2031年
出版日: 2024年11月18日
発行: SkyQuest
ページ情報: 英文 192 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

静注液の世界市場規模は、2022年に119億9,000万米ドルと評価され、2023年の129億5,000万米ドルから2031年には239億6,000万米ドルに成長し、予測期間(2024-2031年)のCAGRは8.0%で成長する見通しです。

世界の静注液市場は、慢性疾患の増加、在宅ヘルスケアサービスの需要増、高齢者人口の急増などを主な要因として、堅調な伸びを示しています。これらの無菌液体は、水分補給、栄養補給、薬物や電解質の投与など、患者のケアにおいて重要な役割を果たしています。特に輸液装置における技術の進歩は、持続可能な製造・パッケージング方法への業界のシフトとともに、市場拡大をさらに後押ししています。しかし、競合情勢に課題がないわけではなく、厳しい規制状況、高い製造コスト、新興企業と既存企業間の競合激化などが成長の障害となっています。こうしたハードルにもかかわらず、特に栄養静注液への注目の高まりや個別化医療戦略への需要の高まりによって、新たな機会が生まれつつあります。市場の発展に伴い、利害関係者はこうした複雑な状況を乗り切ると同時に、技術革新と消費者の嗜好の変化を活用して、 2024-2031 87文字 静注液分野でのポジショニングを高める必要があります。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 技術の進歩
  • 規制情勢
  • 特許分析
  • バリューチェーン分析
  • PESTEL分析
  • マクロ経済指標
  • サプライチェーン分析
  • 価格分析

静注液の市場規模:製品別

  • 完全静脈栄養
  • 末梢静脈栄養

静注液の市場規模:栄養素別

  • 炭水化物
  • ビタミンとミネラル
  • 単回投与アミノ酸
  • 非経口脂質乳剤
  • その他

静注液市場規模:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州地域
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021-2023)

主要企業プロファイル

  • Akshar Pharma
  • Fresenius Kabi AG
  • MEDEVAC LIFESCIENCES PVT LTD
  • Pfizer, Inc.
  • LXIR MEDILABS PVT. LTD
  • Otsuka Pharmaceutical Co., Ltd.
  • Baxter
  • B. Braun
  • Melsungen AG
  • Aishwarya Healthcare
  • Vifor Pharma Management Ltd.
  • JW Life Science
  • Amanta Health Care
  • ICU Medical, Inc.
  • Grifols S.A.
  • AptarGroup, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Amgen Inc.
  • Novartis AG

結論と推奨事項

目次
Product Code: SQMIG35E2051

Global Intravenous Solutions Market size was valued at USD 11.99 Billion in 2022 and is poised to grow from USD 12.95 Billion in 2023 to USD 23.96 Billion by 2031, growing at a CAGR of 8.0% in the forecast period (2024-2031).

The global intravenous (IV) solutions market is showing robust growth, primarily driven by an increase in chronic disease prevalence, heightened demand for home healthcare services, and a burgeoning elderly population. These sterile liquids serve crucial roles in patient care-providing hydration, nutritional support, and the administration of medications and electrolytes. Technological advancements, particularly in infusion devices, along with an industry shift towards sustainable manufacturing and packaging methods, are further propelling market expansion. However, the landscape is not without challenges; stringent regulatory requirements, high manufacturing expenses, and intensifying competition between emerging and established firms present obstacles to growth. Despite these hurdles, new opportunities are emerging, especially with a heightened focus on nutritional IV solutions and the rising demand for personalized medicine strategies. As the market evolves, stakeholders must navigate these complexities while capitalizing on innovation and shifting consumer preferences to enhance their positioning in the intravenous solutions sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Solutions Market Segmental Analysis

Global Intravenous Solutions Market is segmented by Product, Nutrients, and region. Based on Product, the market is segmented into Total Parenteral Nutrition, Peripheral Parenteral Nutrition. Based on Nutrients, the market is segmented into Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids, Parenteral Lipid Emulsion, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Intravenous Solutions Market

The Global Intravenous Solutions market is experiencing significant growth due to the remarkable rise in home healthcare services. An increasing number of patients are opting for treatments in the comfort of their own homes, particularly those managing chronic conditions, which is driving the demand for home-based IV and infusion therapies. This shift not only enhances patient comfort but also improves treatment adherence, prompting healthcare professionals to expand their offerings of intravenous solutions specifically for home use. As a result, the market is witnessing a surge in demand for adaptable and convenient intravenous therapies that cater to the evolving preferences of patients.

Restraints in the Global Intravenous Solutions Market

The Global Intravenous Solutions market faces significant restraints primarily due to safety concerns and the potential for contamination during the administration or production of IV technologies. These issues can lead to increased regulatory scrutiny and challenges, ultimately hindering the widespread adoption of these solutions and stunting market growth. Furthermore, patients might experience side effects from specific intravenous therapies, which could cause hesitation among healthcare professionals in utilizing such products. This apprehension not only affects the confidence of providers but also contributes to a reluctance in recommending IV treatments, further impacting the overall trajectory of the market.

Market Trends of the Global Intravenous Solutions Market

The Global Intravenous Solutions market is witnessing a significant trend towards home infusion therapy, driven by advancements in portable infusion technologies that enhance patient comfort and outcomes. This shift not only reduces the reliance on hospital admissions but also allows individuals with chronic diseases to receive their treatments in a familiar environment. The integration of telehealth services further supports this trend by enabling healthcare providers to remotely monitor patients, ensuring timely interventions and personalized care. As a result, the market is poised for growth, with increasing demand for innovative intravenous solutions that cater to the evolving needs of patients and healthcare systems.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Supply Chain Analysis
  • Pricing Analysis

Global Intravenous Solutions Market Size by Product & CAGR (2024-2031)

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

Global Intravenous Solutions Market Size by Nutrients & CAGR (2024-2031)

  • Carbohydrates
  • Vitamins & Minerals
  • Single-dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others

Global Intravenous Solutions Market Size & CAGR (2024-2031)

  • North America, (Product, Nutrients)
    • US
    • Canada
  • Europe, (Product, Nutrients)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product, Nutrients)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product, Nutrients)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product, Nutrients)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Akshar Pharma
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MEDEVAC LIFESCIENCES PVT LTD
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LXIR MEDILABS PVT. LTD
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Otsuka Pharmaceutical Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Melsungen AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aishwarya Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vifor Pharma Management Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • JW Life Science
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amanta Health Care
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Grifols S.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AptarGroup, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sagent Pharmaceuticals, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Amgen Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation